Lower Antiplatelet Effect of Aspirin in Essential Thrombocythemia than in Coronary Artery Disease

Background  Patients with essential thrombocythemia (ET) and coronary artery disease (CAD) have increased risk of thromboembolic complications. In addition, a reduced antiplatelet effect of aspirin has been demonstrated in both patient groups. As ET is a platelet disorder, platelets may be more impo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Oliver Buchhave, Hvas, Anne-Mette, Ommen, Hans Beier, Kristensen, Steen Dalby, Grove, Erik Lerkevang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255105/
https://www.ncbi.nlm.nih.gov/pubmed/34235392
http://dx.doi.org/10.1055/s-0041-1731309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255105/
https://www.ncbi.nlm.nih.gov/pubmed/34235392
http://dx.doi.org/10.1055/s-0041-1731309

Ejemplares similares